GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Anbenitamab to gain competitive edge as first bispecific mAb in HER-positive gastric cancer market in China, says GlobalData

China’s National Medical Products Administration (NMPA) has recently accepted the New Drug Application (NDA) of Alphamab Oncology’s KN026 (anbenitamab). If approved, KN026 is expected to become the first bispecific monoclonal antibody (mAb) targeting HER2-positive gastric or gastroesophageal (GEJ) carcinoma and evolve as a potential treatment option in the gastric cancer landscape in China, says GlobalData, […]
Read more

India dental implants and abutments market to grow at 6% CAGR through 2034, forecasts GlobalData

India’s dental implants and abutments market is entering a decade of structural change, driven less by sheer volume growth and more by a shift in expectations from both patients and practitioners. The conversation is moving away from affordability alone toward reliability, aesthetics, and clinical outcomes. Reflecting this shift, India’s dental implants and abutments market is […]
Read more

Influencers see Nvidia’s $100 billion investment in OpenAI reshaping AI landscape, reveals GlobalData

OpenAI Inc. became a trending company among influencers on ‘X’ this week due to a significant strategic partnership with NVIDIA, involving an investment of up to $100 billion. The scale of this project, involving 10 gigawatts of NVIDIA systems and millions of GPUs, has captured the attention of influencers, highlighting the immense capital expenditure required […]
Read more

Verizon Business need to showcase advantages it holds over competitors, says GlobalData

In September 2025, Verizon Business held an ‘Innovation Session’ for enterprise, small business, and public sector customers, its fourth of six for the year. Although the event was valuable, Verizon Business could position itself more effectively at future events by placing greater emphasis on advantages the company holds over competitors, its customer support capabilities, and […]
Read more

US VC funding value soars 64% YoY even as deal volume dips 5% during January-August 2025, finds GlobalData

The US venture capital (VC) landscape registered a 64% year-on-year (YoY) surge in funding value during January to August 2025 even as deal activity slipped 5%. Investors are backing fewer but larger deals, signaling a preference for scale and impact. With landmark billion-dollar raises, the US has reinforced its dominance in global VC funding, reveals […]
Read more

India 3T MRI systems market to grow at 12% CAGR through 2036, forecasts GlobalData

India’s medical imaging sector is undergoing rapid transformation with hospitals increasingly adopting advanced magnetic resonance imaging (MRI) systems to improve diagnostic accuracy. Against this backdrop, the 3T MRI systems market in India is anticipated to grow at a compound annual growth rate (CAGR) of approximately 12% between 2024 and 2036, forecasts GlobalData, a leading data […]
Read more

Cadillac’s ad campaigns highlight performance, personalization, and eco-responsibility, reveals GlobalData

Cadillac’s YouTube advertising campaigns from June to August 2025 showcase a focus on electric luxury models, emphasizing innovation, sustainability, and premium experiences. From the sophisticated ESCALADE IQ to the bespoke CELESTIQ, Cadillac’s advertisements resonate with individuals who value technology and high-quality craftsmanship. By showcasing advanced driver assistance systems, customized design features, and eco-friendly performance, Cadillac […]
Read more

Johnson & Johnson to face fierce competition from Boston Scientific in US electrophysiology device market, says GlobalData

Johnson & Johnson and Boston Scientific are currently the companies with the largest market shares in the US electrophysiology devices market. Johnson & Johnson has held majority market share for over a decade. From Q4 2024 to present, Boston Scientific’s Farawave pulsed field ablation catheter has maintained its place as the highest revenue product line […]
Read more

Breakthroughs in idiopathic pulmonary fibrosis may lead to first approval in years, says GlobalData

After years of limited progress, new treatments for idiopathic pulmonary fibrosis (IPF) are moving closer to approval. Boehringer Ingelheim’s nerandomilast has shown strong Phase III results and could secure approval later in 2025, while United Therapeutics’ inhaled treprostinil advances in late-stage trials, signaling a potential breakthrough for patients facing this debilitating lung disease, says GlobalData, […]
Read more

Hong Kong (China SAR) payment card market to surpass $230 billion in 2029, forecasts GlobalData

Hong Kong (China SAR) payment card transaction value (including point of sale (POS) payments and ATM cash withdrawals) is expected to reach HKD1.8 trillion ($233.6 billion) in 2029, supported by well-developed banking and payment infrastructure, and the growing preference for contactless payments, reveals GlobalData, a leading data and analytics company. GlobalData’s Payment Card Analytics reveals […]
Read more

APAC deal activity holds steady as M&A and select markets drive growth during January-August 2025, finds GlobalData

The Asia-Pacific (APAC) deal landscape (comprising mergers & acquisitions (M&A), private equity, and venture financing deals) exhibited modest expansion in the January-August 2025 period, underpinned by an increase in M&A activity and notable growth in some markets. Total deal volume across the region increased by around 1% during the first eight months of 2025 compared […]
Read more

FDA ends HAE drought with record approvals in 2025, reveals GlobalData

After four years of inactivity, the FDA approved three novel products for hereditary angioedema (HAE) in 2025. This bumper year increased the total number of marketed innovator drugs in the US to 11, introducing new mechanisms and modalities that broaden the treatment strategies available to patients, according to GlobalData, a leading data and analytics company. […]
Read more

Global deal activity down 3% YoY during January-August 2025, but some bright spots emerge, finds GlobalData

Global deal activity witnessed a year‑on‑year (YoY) decline during January-August 2025, with contractions across all deal types and most of the regions, even as pockets of resilience and growth emerged. The total number of deals (comprising mergers & acquisitions (M&A), private equity and venture financing deals) announced globally fell by around 3% during January-August 2025 […]
Read more

GlobalData’s AI platform reveals six emerging bakery ingredients driving category innovation in 2025

Bakery ingredients identified by GlobalData’s Ai Palette platform are already appearing in new product innovation, tempting consumers with novelty flavors, nutritional recipes, and premium formulations. GlobalData’s Ai Palette innovation and consumer insights platform has analyzed the data from thousands of ingredients, pinpointing six that offer brands the opportunity to align with evolving consumer trends in […]
Read more
1 48 49 50 51 52 777